ARCHIVES

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

This article is from The Cancer Letter archive.

Vol. 11 No. 32 | August 9, 1985

Download PDF Visit The Full Archive

Related Articles

Cancer Meetings Listed

October 24, 1997

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

FDA Seeks Consumers For Advisory Committees.

November 23, 2001

NCI To Fund Two Construction Grants With 42 Million From Special NIH Fund

March 2, 1990

Sweden Approves Photofrin For Palliation Of Two Cancers.

July 28, 2000

New NCI Director Varmus “Glad To Be Back,” Says Goal Is To Control Cancer Through Science

July 16, 2010